NHANES 2017–2018 elastography data (n=4102) linked to mortality showed 59 deaths over ~24 months; decedents were older and more likely to have diabetes. MASLD (CAP ≥274 dB/m) with diabetes carried ...

The activation of hepatic stellate cells (HSCs) is a key process in the pathogenesis of liver fibrosis, but the molecular mechanisms behind it are not fully understood. By combining the analysis of ...

(A) Multiple environmental and genetic factors have been associated with MASLD. Most significant ones are highlighted here. (B) Several strong genetic risk factors for MASLD are highlighted here. ALT, ...

Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression of chronic liver diseases such as chronic hepatitis and metabolic ...

This study investigates the association between liver fibrosis and diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes mellitus ...

New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better ...

Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to ...

Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater ...